Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

• Martin Šíma,
• Andrea Laslop,
• John Joseph Borg,
• John Joseph Borg,
• Silvester Poništ,
• Daniela Melchiorri,
• František Dráfi,
• František Dráfi

Affiliations

Martin Šíma

Institute of Pharmacology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czechia

Andrea Laslop

Agency for Health and Food Safety (AGES), Vienna, Austria

John Joseph Borg

Malta Medicines Authority, Sir Temi Żammit Buildings, Malta Life Sciences Park, San Gwann, Malta

John Joseph Borg

School of Pharmacy, Department of Biology, University of Tor Vergata, Rome, Italy

Silvester Poništ

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS Bratislava, Bratislava, Slovakia

Daniela Melchiorri

Department of Physiology and Pharmacology, Sapienza University, Rome, Italy

František Dráfi

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine SAS Bratislava, Bratislava, Slovakia

František Dráfi

State Institute for Drug Control, Bratislava, Slovakia